CT0181
/ CARsgen
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 04, 2021
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1; N=13; Recruiting; Sponsor: Peking University; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
July 22, 2021
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1; N=1; Not yet recruiting; Sponsor: Peking University
Clinical • New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
1 to 2
Of
2
Go to page
1